MedTrace Logo

Sleep and Nocturnal Melatonin in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

NCT01329510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2011-04-06

No results posted yet for this study

Summary

This study will investigate the effects of methylphenidate on sleep in adults with Attention Deficit/ Hyperactivity Disorder (ADHD) using polysomnographic parameters.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DEVICE

One-night polysomnographic recordings

One-night polysomnographic recordings before and during methylphenidate treatment.

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    lead OTHER_GOV

Principal Investigators

  • Michael Khaigrekht, MD · Memory, Attention And Learning Disabilities Unit, Assaf Harofeh Medical Center

  • Ran Shorer, M.A. · Memory, Attention And Learning Disabilities Unit, Assaf Harofeh Medical Center

  • Martin Rabey, MD · Neurology Department , Assaf Harofeh Medical Center

  • Itzhak Shpirer, MD · Sleep And Snoring Clinic, Assaf Harofeh Medical Center

  • Shoky Shavit, M.A · Memory, Attention And Learning Disabilities Clinic, Assaf Harofeh Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2006-12-31
Completion
2007-05-31

Countries

  • Israel

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01329510 on ClinicalTrials.gov